Paper17516860
Zapotin, a phytochemical present in a Mexican fruit, prevents colon carcinogenesis.
Murillo G and 6 others. Nutr Cancer, 2007. Cited by 17 papers, by iCite.
Cite this record
ConductScience Library. Zapotin, a phytochemical present in a Mexican fruit, prevents colon carcinogenesis. Papers, record 17516860. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/17516860
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics20
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Anticarcinogenic Agents | Major topic |
| Cell Division | Major topic |
| Colon | Major topic |
| Colonic Neoplasms | Major topic |
| Flavones | Major topic |
| Manilkara | Major topic |
| Animals | |
| Apoptosis | |
| Azoxymethane | |
| Carcinogens | |
| Cell Line, Tumor | |
| Disease Models, Animal | |
| Dose-Response Relationship, Drug | |
| Flow Cytometry | |
| HT29 Cells | |
| Humans | |
| Mice | |
| Mice, Inbred Strains | |
| Precancerous Conditions | |
| Time Factors |
Source PubMed
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| P01 CA48112 | NCI NIH HHS | United States | P01CA048112 | PubMed and NIH |
Source NIH RePORTER
Cited by7
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 17 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42293272 | Bioactive potential of Rhododendron lowndesii: Extraction, antioxidant analysis, antimicrobial assay, and Liquid Chromatography-mass Spectrometry profiling. | J Adv Pharm Technol Res | 2026 | https://conductscience.org/library/papers/42293272 | PubMed |
| 40296014 | Zapotin mitigates breast cancer progression by targeting PKCε mediated glycolytic pathway regulation. | BMC Cancer | 2025 | https://conductscience.org/library/papers/40296014 | PubMed |
| 38795134 | The Emerging Role of Natural Products in Cancer Treatment. | Arch Toxicol | 2024 | https://conductscience.org/library/papers/38795134 | PubMed |
| 36765950 | Phenolic Phytochemicals for Prevention and Treatment of Colorectal Cancer: A Critical Evaluation of In Vivo Studies. | Cancers (Basel) | 2023 | https://conductscience.org/library/papers/36765950 | PubMed |
| 34948021 | Zapotin, a Polymethoxyflavone, with Potential Therapeutic Attributes. | Int J Mol Sci | 2021 | https://conductscience.org/library/papers/34948021 | PubMed |
| 22381066 | The tetramethoxyflavone zapotin selectively activates protein kinase C epsilon, leading to its down-modulation accompanied by Bcl-2, c-Jun and c-Fos decrease. | Eur J Pharmacol | 2012 | https://conductscience.org/library/papers/22381066 | PubMed |
| 20716634 | Enhanced induction of mucin-depleted foci in estrogen receptor {beta} knockout mice. | Cancer Prev Res (Phila) | 2010 | https://conductscience.org/library/papers/20716634 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/17516860
GET https://conductscience.org/api/papers/v1/17516860/authors